ALERT: Globe Advisor Client Management Changes
Client Center will be decommissioned December 31, 2018. Read More


MEDRELEAF CORP. is a licensed producer of cannabisbased pharmaceutical products. The Company cultivates and produces its cannabis-based pharmaceutical products including dried cannabis, cannabis oils, and cannabis oil capsules.

Click here to print this page.
Symbol: N/A
Exchange(s): N/A
Industry: Agriculture (Other Agricultural Products)
5-Star Rating:
  Mar 31, 2017
12 Months
Mar 31, 2016
12 Months
Mar 31, 2015
12 Months
% Change
Total Revenue ($000) 40,414 19,353 3,014 N/A
Earnings before Interest & Tax ($000) 15,763 3,489 -647 N/A
Profit/Loss ($000) 10,958 2,531 -724 N/A
Earnings per Share 16.35 4.40 -1.64 N/A
Total Assets ($000) 74,885 20,011 8,882 N/A
Dividends Per Share 0.00 0.00 0.00  
Return on Com. Equity 33.24 29.10 N/A  
Employees 135 133 N/A  
Trailing 12 Month Results
  12 Months ended
Dec 31, 2017, C$
Total Revenue ($000) N/A N/A
Profit/Loss ($000) N/A N/A
Earnings per Share N/A N/A
Dividends Per Share 0.00
Number of Shares 94,798,783  
Report on Business Magazine Top 1000 Ranking
Profit: 0353 Revenue: 0578 Assets:  0701  
Contact Information
Address: 200 Bay Street,
Suite 3800,
M5J 2Z4
Phone: 289-317-1004
Web Address:
E-Mail :
Company Type: Defunct  
Auditors: Kpmg Llp
Transfer Agent: Tsx Trust Company
Incorporation: Canada, Feb 28, 2013

All information on this site is compiled by The Globe and Mail Inc. from reliable industry sources. While all efforts are made to ensure the accuracy of the information, The Globe and Mail Inc. and its related entities assume no liability for incorrect, incomplete, or missing information from this site. Past performance is not necessarily indicative of future performance. Prior to making any investment decision, consult with a qualified investment advisor.

Copyright © 2019 The Globe and Mail Inc. All rights reserved.